SCHEMBL25243173

SCHEMBL25243173

NC(=O)Cc1ncccc1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
ALDH1A1 P00352 3/20 0.41
MKNK1 Q9BUB5 2/20 0.39
MKNK2 Q9HBH9 2/20 0.39
NAPRT Q6XQN6 1/20 0.39
ADORA2A P29274 3/20 0.38
ADORA1 P30542 1/20 0.38
CTNNB1 P35222 2/20 0.38
WNT3A P56704 2/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
KDM1A O60341 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
CNR2 P34972 1/20 0.36
ARG1 P05089 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29781414 0.83 KDM4E (0.49) MAPTNAPRTCTNNB1WNT3AKDM1A
SCHEMBL4535820 0.83 KDM4E (0.49) MAPTNAPRTCTNNB1WNT3AKDM1A
SCHEMBL4662762 0.82 MPO (0.43) MAPTHTTALDH1A1MKNK1MKNK2
SCHEMBL17921258 0.81 NAPRT (0.39) MAPTHTTALDH1A1NAPRTADORA2A
SCHEMBL21379921 0.81 CYP1A2 (0.49) MAPTHTTALDH1A1ADORA2AADORA1
SCHEMBL16320453 0.80 ALDH1A1 (0.39) MAPTHTTALDH1A1NAPRTADORA2A
SCHEMBL4668812 0.79 L3MBTL1 (0.57) MAPTALDH1A1NAPRTL3MBTL1KDM1A
SCHEMBL27612752 0.79 KDM4E (0.44) MAPTHTTALDH1A1NAPRTL3MBTL1
SCHEMBL18975638 0.79 L3MBTL1 (0.39) ALDH1A1NAPRTADORA2AADORA1CTNNB1
SCHEMBL6513742 0.78 PLAU (0.44) MAPTHTTMKNK1MKNK2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023118092-A1 PYRAZOLO[1,5-A]PYRIDO[3,2-E]PYRIMIDINES AND PYRAZOLO[1,5-A][1,3]THIAZOLO[5,4-E]PYRIMIDINES AS P2X3 INHIBITORS FOR THE TREATMENT OF NEUROGENIC DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 2023-06-29 WO disclosed